Stoke Therapeutics Inc (NASDAQ:STOK)
| 11.71 Delayed Data As of Jun 09 |  -0.98 / -7.72%Today’s Change | 6.88 Today|||52-Week Range 22.87 | +26.87% Year-to-Date |
Latest STOK News | Press Releases
No recent news for Stoke Therapeutics Inc.
Today’s Trading
| Previous close | 12.69 |
| Today’s open | 12.55 |
| Day’s range | 11.68 - 12.55 |
| Volume | 8,616 |
| Average volume (3 months) | 272,865 |
| Market cap | $525.4M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -11.25% |
| Earnings growth (this year) | +4.59% |
| Earnings growth (next 5 years) | -1.02% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 28.94 |
| Price/Book | 2.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CHRSCoherus BioSciences ... | +0.04 | +0.74% |
| AUTLAutolus Therapeutics... | -0.05 | -1.71% |
| ANABAnaptysBio Inc | +0.42 | +2.29% |
| ALPNAlpine Immune Scienc... | -0.13 | -1.25% |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $12.4M |
| Annual profit (last year) | -$101.1M |
| Net profit margin | -814.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bedford, Massachusetts |
Forecasts
